• Return to HOME


  • Home
  • Services
    • Clinical & Medical Consulting
    • Business Development
    • Pharmaceutical
    • Regulatory Affairs
    • Legal Consulting
  • Our Team
    • Michael Epstein, MD, FACG, AGAF
  • News
  • Blog
  • Contact


Services

  • Clinical & Medical Consulting

    Our consulting services are second to none. Let our team guide you through the intensive processes concerning clinical research, medical device and technology, and regulatory affairs.

  • Business Development

    Assessment of new therapeutic areas/opportunities Evaluation of partnership opportunities Evaluation of product opportunities Evaluation of other business development opportunities

  • Pharmaceutical

    Epstein Associates assists with Post Marketing Safety Surveillance, regulatory consulting, protocol writing, CRF creation, and researchClinical Development study design.

  • Regulatory Affairs

    Our services include the development of a comprehensive panel strategy for the sponsor including organizing a slide presentation, streamlining Q & A and creating a Post Panel Action Report.

  • Legal Consulting

    Legal Consulting, Pharmaceutical Patent Consulting, Patent Infringement and Device Infringement Reglan (Metoclopramide), Imuran (Azathioprine), Lialda (Mesalamine),  Trexall/Rheumatrex (Methotrexate) Medical malpractice expert for both plaintiff and defendant; patent cases  

Key Services

  • Clinical & Medical Consulting
  • Business Development
  • Pharmaceutical
  • Regulatory Affairs
  • Legal Consulting

News & Announcements

Achieving successful bowel preparation with evening/morning split-dosing regimens of NER1006 versus trisulfate: post hoc analysis of a Phase 3 trial
Jul 25, 2017
Novel 1L Polyethylene Glycol (PEG)-Based Bowel Preparation NER1006 Achieves High Quality Bowel Cleansing with a Lower Volume than Standard 2L PEG + Ascorbate and Under 3L Total Fluid Volume Intake
Jul 25, 2017
Bowel preparation quality of NER1006 versus oral trisulfate solution as assessed by colonoscopists at site: a post hoc analysis from a randomized controlled trial
Jul 25, 2017

410-224-4887 x453

Epstein Associates, LLC
621 Ridgely Avenue, Suite 204
Annapolis, MD 21401

  • Home
  • Services
  • Our Team
  • News
  • Blog
  • Contact

© Copyright 2015, Epstein Associates, LLC
Website Design by Calvert Design Group, Inc.